Medtronic (Minneapolis) could be one step closer in its bid to have drug eluting stents (DES) treat erectile dysfunction. Last week, the med-tech giant reported that it had completed its ZEN (Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males with Sub-Optimal Response to PDE5 Inhibitors), feasibility study.